The National Cancer Institute is offering the Innovative Technologies in Biospecimen Science Grant to fund groundbreaking research projects that focus on developing innovative cancer-relevant technologies for biospecimen science. Projects should aim to enhance the quality and utility of biospecimens for molecular analyses while prioritizing donor/patient health. The grant supports the development of tools, devices, and methods to assess sample quality, preserve integrity, and establish quality control criteria. This opportunity is part of the NCI’s Innovative Molecular Analysis Technologies Program and utilizes the R21 grant mechanism. Applications are due by September 30, 2009.
Opportunity ID: 44373
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-09-004 |
| Funding Opportunity Title: | Innovative and Applied Emerging Technologies in Biospecimen Science (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.392 — Cancer Construction |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 15, 2008 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 30, 2009 |
| Current Closing Date for Applications: | Sep 30, 2009 |
| Archive Date: | Oct 31, 2009 |
| Estimated Total Program Funding: | $1,000,000 |
| Award Ceiling: | $275,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments For profit organizations other than small businesses Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Non-domestic (non-U.S.) Entities (Foreign Organizations); U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exceptionally innovative, high risk, original and/or unconventional exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies for biospecimen science. The overall goal is to develop and evaluate technologies capable of interrogating and/or maximizing the quality and utility of biospecimens for molecular analyses with minimal invasiveness or compromise to donor/patient health. This FOA will also support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. Projects must clearly demonstrate potential to produce a major impact in the area of biospecimen science.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs. See NOT-CA-09-007.
Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with a FOA of identical scientific scope, RFA-CA-09-005, that solicits applications under the NIH Exploratory/Developmental Phase II Research Grant (R33) award mechanism. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-004.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-A | Adobe-Forms-A | PKG00009692 | Jan 23, 2009 | Sep 30, 2009 | View |
Package 1
Mandatory forms
44373 RR_SF424-1.1.pdf
44373 RR_KeyPersonExpanded-1.1.pdf
44373 RR_OtherProjectInfo-1.1.pdf
44373 RR_PerformanceSite-1.1.pdf
44373 PHS398_CoverPageSupplement-1.1.pdf
44373 PHS398_ResearchPlan-1.1.pdf
44373 PHS398_Checklist-1.1.pdf
Optional forms
44373 PHS398_CoverLetter-1.1.pdf
44373 PHS398_ModularBudget-1.1.pdf
44373 RR_Budget-1.1.pdf
44373 RR_SubawardBudget-1.2.pdf
Leave a Reply